| Drug Name | Clexane (enoxaparin sodium) |
|---|---|
| Drug Class |
Anticoagulant
|
| Risk minimization type |
Direct Healthcare Professional Communication DHPC
|
| Specialty (Theraputic area) |
Hematology
|
| Risk |
Updates to strength expression, dose regimens in DVT/PE, use in patients with severe renal impairment |
| Dear Healthcare provider letter DHPC |
|